167 related articles for article (PubMed ID: 23600397)
1. Mechanisms of neurotoxicity and implications for neurological disorders.
Ceccatelli S
J Intern Med; 2013 May; 273(5):426-8. PubMed ID: 23600397
[No Abstract] [Full Text] [Related]
2. Unifying mechanisms of neurological disorders--scientific, translational and clinical implications: overview and theme of the 26th International Neurotoxicology Conference.
Cranmer JM; Reuhl KR; Richardson JR; Lang LA
Neurotoxicology; 2011 Oct; 32(5):499-501. PubMed ID: 22128403
[No Abstract] [Full Text] [Related]
3. Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment.
Volz TJ; Fleckenstein AE; Hanson GR
Addiction; 2007 Apr; 102 Suppl 1():44-8. PubMed ID: 17493052
[TBL] [Abstract][Full Text] [Related]
4. Toxic encephalopathy.
Dobbs MR
Semin Neurol; 2011 Apr; 31(2):184-93. PubMed ID: 21590623
[TBL] [Abstract][Full Text] [Related]
5. Neurological risks associated with manganese exposure from welding operations--a literature review.
Flynn MR; Susi P
Int J Hyg Environ Health; 2009 Sep; 212(5):459-69. PubMed ID: 19181573
[TBL] [Abstract][Full Text] [Related]
6. The role of dopamine receptors in the neurotoxicity of methamphetamine.
Ares-Santos S; Granado N; Moratalla R
J Intern Med; 2013 May; 273(5):437-53. PubMed ID: 23600399
[TBL] [Abstract][Full Text] [Related]
7. Why do we need an Addiction supplement focused on methamphetamine?
Rawson RA; Condon TP
Addiction; 2007 Apr; 102 Suppl 1():1-4. PubMed ID: 17493048
[TBL] [Abstract][Full Text] [Related]
8. NeuroAIDS in Brazil.
Ellis RJ; Joseph J; de Almeida SM
J Neurovirol; 2007 Apr; 13(2):89-96. PubMed ID: 17505977
[TBL] [Abstract][Full Text] [Related]
9. Neurotoxicity of cancer chemotherapy.
Dropcho EJ
Semin Neurol; 2004 Dec; 24(4):419-26. PubMed ID: 15637653
[TBL] [Abstract][Full Text] [Related]
10. The dopamine transporter: role in neurotoxicity and human disease.
Bannon MJ
Toxicol Appl Pharmacol; 2005 May; 204(3):355-60. PubMed ID: 15845424
[TBL] [Abstract][Full Text] [Related]
11. Movement disorders.
Minagar A; Kelley RE
Prim Care; 2004 Mar; 31(1):111-27. PubMed ID: 15110162
[No Abstract] [Full Text] [Related]
12. [Prognosing the development of toxic encephalopathy after exposure to a complex of chemical substances in fire fighters].
Lakhman OL; Katamanova EV; Shevchenko OI
Med Tr Prom Ekol; 2008; (8):12-6. PubMed ID: 18942464
[TBL] [Abstract][Full Text] [Related]
13. Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation.
Bal-Price AK; Coecke S; Costa L; Crofton KM; Fritsche E; Goldberg A; Grandjean P; Lein PJ; Li A; Lucchini R; Mundy WR; Padilla S; Persico AM; Seiler AE; Kreysa J
ALTEX; 2012; 29(2):202-15. PubMed ID: 22892558
[No Abstract] [Full Text] [Related]
14. [Biomarkers of neurotoxic effects induced by environmental chemicals].
Indulski JA; Lutz W
Med Pr; 1996; 47(4):383-91. PubMed ID: 8847985
[TBL] [Abstract][Full Text] [Related]
15. Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity.
Kita T; Miyazaki I; Asanuma M; Takeshima M; Wagner GC
Int Rev Neurobiol; 2009; 88():43-64. PubMed ID: 19897074
[TBL] [Abstract][Full Text] [Related]
16. Manganese neurotoxicity: a review of clinical features, imaging and pathology.
Pal PK; Samii A; Calne DB
Neurotoxicology; 1999; 20(2-3):227-38. PubMed ID: 10385886
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the risk of manganese-induced neurotoxicity of parenteral nutrition: review of the current literature.
Martins AC; Ruella Oliveira S; Barbosa F; Tinkov AA; V Skalny A; Santamaría A; Lee E; Bowman AB; Aschner M
Expert Opin Drug Metab Toxicol; 2021 May; 17(5):581-593. PubMed ID: 33620266
[TBL] [Abstract][Full Text] [Related]
18. Epidemiologic studies of environmental exposures in Parkinson's disease.
Elbaz A; Tranchant C
J Neurol Sci; 2007 Nov; 262(1-2):37-44. PubMed ID: 17673256
[TBL] [Abstract][Full Text] [Related]
19. Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders.
Callaghan RC; Cunningham JK; Sajeev G; Kish SJ
Mov Disord; 2010 Oct; 25(14):2333-9. PubMed ID: 20737543
[TBL] [Abstract][Full Text] [Related]
20. Neurodegenerative memory disorders: a potential role of environmental toxins.
Caban-Holt A; Mattingly M; Cooper G; Schmitt FA
Neurol Clin; 2005 May; 23(2):485-521. PubMed ID: 15757794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
